Stay updated on Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.2 to v3.8.0; the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-11-01T01:02:53.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces that federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434.
    Difference
    0.7%
    Check dated 2026-10-25T01:06:14.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The site footer’s revision number changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T00:57:26.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The website footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T01:28:55.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the study record's version history. The previous v3.6.6 entry was removed, indicating an update to the page's revision history rather than substantive trial data.
    Difference
    0.1%
    Check dated 2026-09-20T00:17:30.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    A new revision entry for v3.6.6 appears in the study record history, replacing the previous v3.6.5. This indicates a platform release update to the ClinicalTrials.gov history page.
    Difference
    0.1%
    Check dated 2026-08-29T19:12:10.000Z thumbnail image

Stay in the know with updates to Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial page.